MyCEI Login


Engaging LGBTQ+ People who Use Drugs: Cultural Responsiveness and Beyond


Published Date: 11/01/2022

Expiration Date: 06/15/2025

CE Credit: CME:1CNE: 1


Research suggests that individuals who identify as LGBTQ+ are at greater risk for substance use and mental health issues, compared with the sexual majority population that identifies as heterosexual. Furthermore, LGBTQ+ clients typically enter substance use disorder treatment with more severe problems, greater psychopathology and greater medical service utilization when compared with heterosexual clients. This course will review the basics of gender and sexuality, including the history of LGBTQ+ alcohol and drug use culture. It will provide participants with an understanding of the principles of culturally informed and responsive care for LGBTQ+ patients with substance use disorder(s).


Effective June 27, 2023 the Drug Enforcement Administration (DEA) and the Substance Abuse and Mental Health Services Administration (SAMHSA) announced a one-time requirement of 8 hours of training on the treatment and management of patients with opioid or other substance use disorders for practitioners who are applying for or renewing their DEA license. This 1-hour ACCME-accredited course meets the DEA/SAMHSA requirement.


Derek Blevins,MD

Derek Blevins, MD is an Assistant Professor of Clinical Psychiatry at Columbia University, a research psychiatrist at the New York State Psychiatric Institute, and a psychiatrist in private practice in Manhattan. He completed his psychiatric residency at the University of Virginia, where he served as chief resident, and a combined clinical and NIDA-funded T32 research fellowship in addiction psychiatry at Columbia University. Dr. Blevins is the clinical implementation coach and technical assistant for the New York site of the NIDA HEALing Communities Study, which aims to reduce opioid overdose deaths by 40%. He is also interested in the application of repetitive transcranial magnetic stimulation and pharmacotherapies for the treatment of stimulant use disorders. In his clinical practice, Dr. Blevins focuses on the treatment of substance use disorders with a special interest in LGBTQ+ individuals.

Learning Objectives

  • Review the basics of gender and sexuality.
  • Explore LGBTQ+ alcohol and drug history culture.
  • Discuss epidemiology and psychiatric comorbidity.
  • Describe key principles of providing culturally informed and responsive treatment to LGBTQ+ individuals with substance use disorder(s).
  • Review examples of clinically relevant evidence for treating LGBTQ+ individuals with substance use disorder(s).

Continuing Education Credit Information